ZDNET's key takeaways Unplug at 100%, and keep the battery between 20% and 80%.Avoid draining to 0%; store unused tablets at ...

Head to Amazon to purchase the HP 24 Touchscreen All-in-One Desktop Computer for only $600, which is down from $1,600, a ...

The hilarious and food-loving Raphael Gomes twists his taste buds by eating sour foods enhanced by taste-changing miracle ...

Hormonal birth control offers women reproductive freedom but can trigger migraines for some. Understanding the link between ...

Cold weather affects your phones, laptops, and tablets more than you’d think. These practical tips will help you sidestep ...

Bihar's recent assembly elections saw the NDA achieve a significant win. The coalition's strategy focused on women-centric ...

Durabook launches the R10, an AI-powered rugged tablet with Intel Core Ultra processors, 16-hour battery life and field-ready ...

Members of the Polish and German episcopate, the apostolic nuncio to Poland and governmental authorities from both countries ...

The ARTISTRY-1 Phase III trial demonstrated that a single-tablet regimen of bictegravir 75 mg/lenacapavir 50 mg maintains viral suppression and simplifies therapy for people living with HIV, ...

Topline results were announced from a phase 3 trial evaluating bictegravir 75mg/lenacapavir 50mg (BIC/LEN), an investigational single-tablet regimen for the treatment of HIV-1.

Every year, people around the world take an astonishing 3.8 trillion doses of medicine. Most of these medicines are swallowed ...